title: Costs associated with blood transfusions in Sweden--the societal cost of autologous, allogeneic and perioperative RBC transfusion.
abstract: Anaemia is characterised by an insufficient number of red blood cells (RBCs) and might occur for different reasons, e.g. surgical procedures are often with associated blood loss. Patients who suffer from anaemia have the option of treatment with blood transfusion or medical treatment. In this study, the societal cost, for the case of Sweden, of RBC transfusion using three different techniques, i.e. allogeneic, autologous and intraoperative transfusion, was estimated. The analysis was based on information from interviews with hospital staff at large Swedish hospitals and from published data. The average cost for a 2 units transfusion was found to be Swedish kronor (SEK) 6330 (702 Euro) for filtered allogeneic RBCs and SEK 5394 (598 Euro) for autologous RBCs for surgery patients. Transfusion reactions accounted for almost 35 per cent of the costs of allogeneic RBC transfusions. The administration cost was found to be much higher for autologous transfusions compared with allogeneic transfusions. The cost of intraoperative erythrocyte salvage was calculated to be SEK 2567 (285 Euro) per transfusion (>4 units).
authors.affiliation: The Swedish Institute for Health Economics (IHE), Lund, Sweden. ag@ihe.se
authors.forename: A H
authors.initials: AH
authors.lastname: Glenngård
authors.forename: U
authors.initials: U
authors.lastname: Persson
authors.forename: C
authors.initials: C
authors.lastname: Söderman
mesh_terms: D000740:Anemia / Q000628:therapy; D001803:Blood Transfusion / Q000191:economics*; D001804:Blood Transfusion, Autologous / Q000191:economics; D017707:Erythrocyte Transfusion / Q000191:economics; D017048:Health Care Costs; D006801:Humans; D019990:Perioperative Care; D013548:Sweden; D065227:Transfusion Reaction